Clinical Trial Update: Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating inhaled cannabinoids versus immediate-release oral opioids for breakthrough cancer pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breakthrough Cancer Pain
• Cancer

Drugs mentioned

• immediate-release oral opioids
• inhaled cannabinoids

Snippet

Sponsor: Tetra Bio-Pharma | Conditions: Cancer, Breakthrough Cancer Pain | Phase 2 | Status: UNKNOWN